TipRanks
COSCIENS Biopharma (DE:ET80)
FRANKFURT:ET80
Germany Market
ET80
COSCIENS Biopharma
RESEARCH TOOLSreports

COSCIENS Biopharma (ET80) Stock News & Sentiment

0 Followers
COSCIENS Biopharma Expands Convertible Debenture Financing With Second Tranche
Premium
Company Announcements
COSCIENS Biopharma Expands Convertible Debenture Financing With Second Tranche
22h ago
COSCIENS Biopharma Swings to First-Half Profit and Cuts Costs as It Exits SEC Reporting
Premium
Company Announcements
COSCIENS Biopharma Swings to First-Half Profit and Cuts Costs as It Exits SEC Reporting
1M ago
COSCIENS Biopharma Restructures Share Capital and Moves to Suspend U.S. Reporting
Premium
Company Announcements
COSCIENS Biopharma Restructures Share Capital and Moves to Suspend U.S. Reporting
2M ago
6K
COSCIENS Biopharma Sets July 3 Effective Date for Share Capital Overhaul and U.S. Reporting Exit
Premium
Company Announcements
COSCIENS Biopharma Sets July 3 Effective Date for Share Capital Overhaul and U.S. Reporting Exit
3M ago
6K
COSCIENS Biopharma Shareholders Approve Capital Restructuring as Board Confirms Puccetti as CEO
Premium
Company Announcements
COSCIENS Biopharma Shareholders Approve Capital Restructuring as Board Confirms Puccetti as CEO
3M ago
6K
COSCIENS Biopharma Calls June 17, 2026 Special and Annual Shareholder Meeting
Premium
Company Announcements
COSCIENS Biopharma Calls June 17, 2026 Special and Annual Shareholder Meeting
4M ago
6K
COSCIENS Biopharma posts sharp Q1 profit and stronger balance sheet in May 2026 filing
Premium
Company Announcements
COSCIENS Biopharma posts sharp Q1 profit and stronger balance sheet in May 2026 filing
4M ago
6K
More DE:ET80 News >

ET80 News on the Web

COSCIENS Biopharma Swings to First-Half Profit and Cuts Costs as It Exits SEC Reporting
TipRanks News
Neutral
COSCIENS Biopharma Restructures Share Capital and Moves to Suspend U.S. Reporting
TipRanks News
Neutral
COSCIENS Biopharma Sets July 3 Effective Date for Share Capital Overhaul and U.S. Reporting Exit
TipRanks News
Neutral
COSCIENS Biopharma Shareholders Approve Capital Restructuring as Board Confirms Puccetti as CEO
TipRanks News
Bullish
COSCIENS Biopharma Inc Annual Shareholders Meeting Transcript
GuruFocus News
Neutral
COSCIENS Biopharma Calls June 17, 2026 Special and Annual Shareholder Meeting
TipRanks News
Bearish
COSCIENS Biopharma posts sharp Q1 profit and stronger balance sheet in May 2026 filing
TipRanks News
Bearish
COSCIENS Biopharma Posts Q1 Profit as German Units Exit and SEC Reporting Cutback Advances
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
DE:ET80
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ET80’s Media Buzz Sentiment?
Currently, no data Available
What is DE:ET80’s weekly average amount of articles?
Currently, no data Available
What is DE:ET80’s News Sentiment?
50% of articles about DE:ET80 were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    VCYTVeracyte
    BMYBristol-Myers Squibb
    SLDBSolid Biosciences
    DFTXDefinium Therapeutics
    LHLabcorp Holdings
    Showing the stocks with the most bullish news sentiment over the past week